throbber

`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 1 of 12 PageID #:2436
`
`1
`
`IN THE UNITED STATES DISTRICT COURT
`NORTHERN DISTRICT OF ILLINOIS
`EASTERN DIVISION
`
`Docket No. 16 C 651
`
`Chicago, Illinois
`December 11, 2017
`9:20 a.m.
`
`)))))))))
`
`HOSPIRA, INC.,
`
`Plaintiff,
`
`vs.
`
`FRESENIUS KABI USA, LLC,
`
`Defendant.
`
`TRANSCRIPT OF PROCEEDINGS - Status
`BEFORE THE HONORABLE REBECCA R. PALLMEYER
`
`APPEARANCES:
`
`For the Plaintiff:
`
`JENNER & BLOCK LLP
`BY: MS. SARA T. HORTON
`MR. YUSUF ESAT
`353 North Clark Street
`Chicago, Illinois 60654
`
`For the Defendant:
`
`SCHIFF HARDIN LLP
`BY: MR. JOEL M. WALLACE
`233 South Wacker Drive, Suite 6600
`Chicago, Illinois 60606
`
`Court Reporter:
`
`FRANCES WARD, CSR, RPR, RMR, FCRR
`Official Court Reporter
`219 S. Dearborn Street, Suite 2144D
`Chicago, Illinois 60604
`(312) 435-5561
`frances_ward@ilnd.uscourts.gov
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 2 of 12 PageID #:2437
`
`2
`
`THE CLERK: 16 C 651, Hospira versus Fresenius Kabi
`
`USA for status.
`
`MS. HORTON: Good morning, your Honor.
`
`Sara Horton and Yusuf Esat for Hospira.
`
`THE COURT: Good morning.
`
`MR. WALLACE: Joel Wallace on behalf of Fresenius
`
`Kabi.
`
`THE COURT: Good morning.
`
`Okay. We are here for status. What's our status?
`
`MS. HORTON: Your Honor, the status is that you
`
`issued a Markman ruling about a month ago.
`
`THE COURT: Right.
`
`MS. HORTON: And in the interim, also, Hospira
`
`filed suit on a related patent against Fresenius Kabi, and
`
`then the parties agreed to file a joint consolidation motion,
`
`which you granted.
`
`THE COURT: Correct.
`
`MS. HORTON: So we have that added into this case.
`
`In its answer, Fresenius Kabi counter-claimed
`
`adding an additional patent. So there are now two additional
`
`patents, aside from the four that were involved in the
`
`underlying case -- the first case, I should say.
`
`We have discussed with Fresenius Kabi a schedule
`
`going forward and how to work these other two patents into
`
`the case.
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 3 of 12 PageID #:2438
`
`3
`
`THE COURT: These are patents held by Fresenius
`
`Kabi?
`
`MS. HORTON: No. Held by Hospira.
`
`THE COURT: Held by Hospira. Okay.
`
`So the counterclaim is for invalidity?
`
`MS. HORTON: The counterclaim is for invalidity. I
`
`believe we have not yet answered the counterclaim. But
`
`it's -- in short, it's a patent that issued sometime between
`
`the time that Hospira first sued Fresenius Kabi and between
`
`the second case that we filed against them. And I believe
`
`Fresenius just wants it litigated all at the same time.
`
`THE COURT: Sure. Okay. We did grant the motion
`
`for reassignment. Remind me of the number of that case so I
`
`can get them both on the same track. We will assume this is
`
`a status in that case as well.
`
`MR. WALLACE: The other case was 17 CV 7903.
`
`THE COURT: Okay. So this will -- today's status
`
`will be deemed a status in 17 C 7903 as well.
`
`Does that include the -- that includes the same
`
`patents that are at issue in this case.
`
`MS. HORTON: Yes.
`
`MR. WALLACE: It includes only two more patents
`
`that were part of the same family of the four patents that
`
`are in the original case. And there are two more patents
`
`from the same family, same inventor, same specification that
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 4 of 12 PageID #:2439
`
`4
`
`issued later, and those have now been all consolidated.
`
`The parties have agreed that the claim construction
`
`from the first case applies to the later, because they
`
`share -- all of the -- I guess two of the terms are in all of
`
`the patent claims as well.
`
`THE COURT: And does the addition of two patents in
`
`the original case -- actually, does the addition of any of
`
`these patents involve additional claims as well?
`
`MS. HORTON: Additional claim terms?
`
`THE COURT: Additional claim terms, yes.
`
`MS. HORTON: Yes, your Honor, they do. It's
`
`unclear, to Hospira at least, whether or not there will need
`
`to be additional claim construction briefing. We actually
`
`assume that there will not be, but we haven't done any
`
`discovery on them yet to understand that.
`
`THE COURT: All right. Well, what we need to do,
`
`then, is get a revised Rule 16 schedule in place based
`
`upon -- I am assuming you are going to at least factor in the
`
`local patent rule schedule, but recognizing that some of the
`
`things that have happened already would eliminate that need
`
`in this case.
`
`So can we set a date for that to happen, for you to
`
`develop a proposed schedule?
`
`MR. WALLACE: We have discussed a proposed
`
`schedule. Right now this is the overarching situation. It's
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 5 of 12 PageID #:2440
`
`5
`
`sort of the impasse between the two parties on setting a
`
`schedule, because of the delay between the claim construction
`
`hearing and the ruling.
`
`THE COURT: A lot of the dates should change,
`
`right.
`
`MR. WALLACE: Well, the issue for Fresenius Kabi is
`
`that its 30-month stay on regulatory approval is expiring in
`
`June.
`
`Fresenius Kabi is interested in launching as soon
`
`as possible at that time. It also implicates whether or not
`
`Hospira would be looking to file a preliminary injunction
`
`motion at that time.
`
`So the two options are, we can either compress our
`
`schedule now to try to get everything prepared and get
`
`everything before the Court for a trial in, for example,
`
`early April, and give the Court enough time to hear all the
`
`evidence and then issue a ruling before the June date
`
`happens.
`
`The other alternative, which is what Hospira is
`
`proposing, is to take a more traditional schedule at this
`
`time, following the local patent rules more closely, which
`
`then would push trial out to probably late summer, early --
`
`around early autumn, late summer. But there is this high
`
`risk that partway through the proceeding everything is going
`
`to put on a fast track when we get around the end of the
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 6 of 12 PageID #:2441
`
`6
`
`exclusivity period.
`
`THE COURT: Of those two options -- you probably
`
`won't like hearing this, but I prefer the first. I would
`
`like to try it in April, if we could.
`
`MS. HORTON: So the issue with that, your Honor,
`
`from Hospira's standpoint, is, that requires, under the
`
`schedule that Fresenius has proposed to us -- what they are
`
`proposing is that all discovery on the two new patents and
`
`any updated discovery on the other four patents, after claim
`
`construction, be completed by January 11th.
`
`That would include any depositions on these two new
`
`patents, one of which Hospira didn't even assert against
`
`Fresenius Kabi, that they are asserting against us. So they
`
`brought this into the case.
`
`They are also proposing that they get a summary
`
`judgment motion in January, but Hospira does not get one
`
`similarly.
`
`We are just not sure how it's actually going to
`
`work, to do all of the discovery on these two new patents
`
`from the other case.
`
`THE COURT: I can short-circuit this by saying that
`
`if we want to try it -- if you want to try it in April, we
`
`can't have any summary judgment proceeding. It wouldn't
`
`work.
`
`It seems to me you have time to get your discovery
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 7 of 12 PageID #:2442
`
`7
`
`done between now and April, and January 11th seems
`
`extraordinarily aggressive to me, given the holidays.
`
`If I said, get discovery done by middle to the end
`
`of February, that seems slightly more realistic, and I think
`
`that could easily accommodate a trial date in April.
`
`MS. HORTON: That might work for fact discovery. I
`
`think the other issue is that we think that there will be
`
`significant expert discovery that hasn't happened yet.
`
`We have infringement issues in this case and
`
`invalidity issues in this case. It's going to be -- there
`
`will be damages experts on secondary considerations of
`
`commercial success. I think there will be probably, at least
`
`on Hospira's side, three or four experts that will be
`
`testifying and having expert reports due and needing to be
`
`deposed. I assume the same on Fresenius Kabi's side.
`
`When we lay out the dates, which we have tried to
`
`do, it seems really aggressive to be able to do contentions,
`
`fact discovery and expert discovery, and a pretrial order
`
`before April.
`
`MR. WALLACE: Your Honor, we have had discussions
`
`with Hospira about this, but the two new patents -- one
`
`patent literally adds -- it includes everything from all the
`
`other patents and merely narrows from any type of
`
`dexmedetomidine to one salt form. And there's really no
`
`dispute that's the only one that's been used by anyone. The
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 8 of 12 PageID #:2443
`
`8
`
`other patent adds a few other steps.
`
`We discussed with Hospira. If they will narrow the
`
`scope of the claims that they want to assert, Fresenius Kabi
`
`is willing to discuss stipulations on infringement to
`
`streamline the case as much as possible, that perhaps this
`
`can be an invalidity-only case, which would make it more
`
`amenable to an April trial.
`
`MS. HORTON: That's true.
`
`MR. WALLACE: I believe those discussions, they
`
`wanted -- in any event, the parties -- what Fresenius Kabi is
`
`proposing is that we do contentions in the month of January.
`
`Basically at the beginning of January, Fresenius Kabi would
`
`send its -- we would simultaneously exchange their
`
`infringement contentions on the new patents, and we would
`
`propose our invalidity contentions, amending the old
`
`contentions and adding in the new patents as well.
`
`And then that would put us at the end of January
`
`for -- or the beginning of February for the responsive
`
`contentions. And then at that point, all that would really
`
`be left is expert discovery.
`
`MS. HORTON: That's actually not at all
`
`inconsistent with what Hospira has agreed with Fresenius
`
`Kabi.
`
`Where, I guess, the rubber hits the road is whether
`
`or not, based on those contentions and what happens there, if
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 9 of 12 PageID #:2444
`
`9
`
`the local rules would then contemplate Markman proceedings.
`
`We don't think there is going to be a need to
`
`construe any other claims, but we just don't know how they
`
`are going to be construing terms.
`
`And then after that, the expert discovery -- you
`
`know, after the contentions, then you do expert reports, and
`
`then you have to depose all these people. And then you have
`
`to do a pretrial order.
`
`So what we were -- what we had proposed to
`
`Fresenius was -- frankly, they had expressed in our
`
`meet-and-confers that -- and Mr. Wallace will correct me if
`
`I'm wrong -- that they were keen to have an early summary
`
`judgment or an early trial.
`
`We, Hospira, thought, okay, well, if you want an
`
`early summary judgment, we wouldn't oppose that. I don't
`
`know what the summary judgment will actually be on, but if
`
`they wanted to do that quickly, we said, go for it,
`
`basically.
`
`If that's case-dispositive, as they think it is,
`
`then that might get us to their end goal anyway.
`
`The other thing I wanted to alert your Honor,
`
`because I should have said it earlier, is, the underlying
`
`four patents from the first case have been -- gone through a
`
`trial in Delaware --
`
`THE COURT: Right.
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 10 of 12 PageID #:2445
`
`10
`
`MS. HORTON: -- in front of Judge Andrews. We are
`
`expecting a ruling in that case this month.
`
`So I think there is probably a high likelihood,
`
`depending on what happens in this case, the parties might be
`
`rushing around trying to figure out how that implicates what
`
`they are doing in this case.
`
`MR. WALLACE: From Fresenius Kabi's point of view,
`
`it's, in many ways, irrelevant. If the patents are found
`
`invalid, we are sure that Hospira would probably appeal that
`
`ruling, which means that Fresenius Kabi still doesn't have
`
`certainty on launching whenever it gets final approval or
`
`not.
`
`If Hospira prevails, then Fresenius Kabi, of
`
`course, would still want to go forward, because we have
`
`unique and separate theories -- I think both parties would
`
`agree with that -- than from what was going on in the
`
`Delaware trial.
`
`THE COURT: If the judge declares parts or all of
`
`the Hospira patent invalid, wouldn't that at least militate
`
`in favor of a settlement of this case?
`
`I mean, it will make a difference however the judge
`
`rules.
`
`MR. WALLACE: Yes, your Honor. It could make a
`
`difference.
`
`There have not been settlement discussions between
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 11 of 12 PageID #:2446
`
`11
`
`the parties. So we are not at this point sure what Hospira's
`
`position is.
`
`THE COURT: And if you try to settle it now, are
`
`you going to be saying, we need to wait until the judge rules
`
`in Delaware?
`
`MS. HORTON: Yes.
`
`THE COURT: That's what I think, too.
`
`All right. Here is what I am going to do. I think
`
`we should develop a schedule that gets us ready for trial by
`
`the end of April. If it is just a validity trial, that could
`
`be fine. It could work out very well.
`
`It sounds to me like both parties agree that we are
`
`not going to need further claims construction proceedings in
`
`this case. So we could probably jettison the whole Markman
`
`issue, and obviously that, unfortunately, generates delay.
`
`I would also heavily discourage any summary
`
`judgment briefing unless it's a straight, single issue that
`
`actually could dispose of the whole case.
`
`Let's set it for status -- I will ask you to
`
`develop a schedule along those lines, and let's set it for
`
`status at the end of January.
`
`In the meantime, as soon as the judge out in
`
`Delaware rules, you can let me know, and let me know whether
`
`or not it makes sense now to start talking about a settlement
`
`at that point.
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`
`Case: 1:16-cv-00651 Document #: 80 Filed: 01/09/18 Page 12 of 12 PageID #:2447
`
`12
`
`So January 31st for status? 9 o'clock?
`
`In the meantime, within the next, say, 10 days, if
`
`you could get a schedule to us, we will enter it.
`
`MS. HORTON: Thank you, your Honor.
`
`MR. WALLACE: Thank you, your Honor.
`
`THE COURT: All right. Thank you. I will see you
`
`in January.
`
`* * * * *
`
`I certify that the foregoing is a correct transcript from the
`record of proceedings in the above-entitled matter.
`
`/s/ Frances Ward_________________________January 9, 2018.
`Official Court Reporter
`F/j
`
`1 2 3 4 5 6 7 8 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket